Industry Insight
Accelerating Innovation and Time-to-Market in Life Sciences through AI-Powered Validation
Artificial intelligence is redefining validation — turning a once time-consuming regulatory hurdle into a powerful driver of innovation and speed to market. This ARC Advisory Group report featuring ValGenesis examines how AI is reshaping validation in regulated industries such as pharmaceuticals and medical devices. The report highlights how ValGenesis’ AI-enabled platform and Smart Agents automate documentation, testing, and lifecycle validation — cutting timelines by up to 50% and improving global consistency.
With the FDA, EMA, and other regulatory authorities advancing frameworks to support AI, industry leaders share how these technologies are delivering measurable ROI and transforming compliance from a burden into a competitive advantage for life sciences manufacturers.
Read the full report to learn more.